Bioseutica's latest news
The food enzyme lysozyme (peptidoglycanN-acetylmuramoylhydrolase; EC 188.8.131.52) is produced from hens eggs by Bioseutica B.V. It is intended to be used in b
Want to improve your protein products' processing quality and biological activities? Try using Ovotransferrin as a lactoferrin substitute.
Bioseutica® and Neova Technologies Inc. are looking for a Customer Service Manager in Zeewolde, The Netherlands, a Plant Manager, and a Production Supervisor in Abbotsford Canada.
Ovotransferrin, a protein abundant in hen egg white, shares many of the same activities as human/bovine lactoferrin.
With emerging trends in the food and pharmaceutical industries, potential applications of egg-derived bioactive compounds were recognized.
BIOSEUTICA is proud to inform that the European Food Safety Authority (EFSA) has just issued its scientific opinions on two applications submitted by NEOVA Technologies Inc (a BIOSEUTICA grou
In spite of the numerous discoveries of new anticancer drugs that work on different intracellular targets, many of these drugs have a considerable drawback as they are nonselective thus causing adv
Coronavirus disease 2019 (COVID-19), caused by SARS coronavirus 2 (SARS-CoV-2), is spreading rapidly with no established effective treatments.
We are excited to announce Healiva SA, an innovative startup venture in Lugano, Switzerland co-founded by Bioseutica BV.
Zeewolde, March 28, 2020
The COVID-19 pandemic worries us all.
Our food production plant in Zeewolde (NL) has been inspected by FDA in October 2019, in accordance with “Preventive Controls and Sanitary Human Food Operations-7303.040 Domestic and Imported Nutr